<DOC>
	<DOCNO>NCT00343434</DOCNO>
	<brief_summary>RATIONALE : A diet use soy-based meal replacement may help survivor breast cancer lose weight improve quality life . PURPOSE : This clinical trial study well soy-based meal replacement work help woman stage I , stage II , stage III breast cancer complete remission lose weight .</brief_summary>
	<brief_title>Soy-Based Meal Replacement Helping Women With Stage I , Stage II , Stage III Breast Cancer Complete Remission Lose Weight</brief_title>
	<detailed_description>OBJECTIVES : - Determine ability recruit survivor estrogen receptor/progesterone receptor ( ER/PR ) -negative stage I-III breast cancer participate 3-month , soy-based , meal-replacement ( Almased® ) weight loss intervention . - Assess patient 's ability adhere intervention protocol . - Measure change anthropometrics ( body weight , bioelectrical impedance , waist circumference ) biomarkers ( serum level glucose , insulin , highly specific C-reactive protein , insulin-like growth factor , insulin-like growth factor bind protein-3 , lipid ) . - Measure change health-related quality life . OUTLINE : This prospective , longitudinal , pilot study . Patients undergo goal-oriented , cognitive-behavioral therapy comprise group counsel weekly 3 week individual counsel month . Weight loss intervention include behavioral technique , dietary modification ( use portion-controlled diet soy-based meal-replacement [ Almased® ] twice daily ) , physical activity ( ≥ 15 minute per day , 6 day week ) , social support . Weight loss monitor weekly patient complete daily log dietary intake physical activity . Therapy continue 12 week . Health-related quality life assess baseline weekly 12 week . Patients undergo blood draw baseline 12 week analysis C-reactive protein , glucose , insulin , insulin-like growth factor ( ILGF ) , ILGF-binding protein-3 . PROJECTED ACCRUAL : A total 25 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Previously diagnose stage IIII breast cancer currently complete remission Completed treatment breast cancer ≥ 6 month ago Free disease last clinic visit Body mass index ≥ 27 Hormone receptor status Estrogen receptor ( ER ) /progesterone receptor ( PR ) negative PATIENT CHARACTERISTICS : Female Menopausal status specify No history soy allergies No uncontrolled blood pressure No uncontrolled hyperthyroidism hypothyroidism Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No diabetes mellitus ( type 1 2 ) No medical , psychiatric , behavioral factor would preclude study participation No definite plan move area study period PRIOR CONCURRENT THERAPY : See Disease Characteristics No concurrent medication weight loss No concurrent treatment ER/PRnegative disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>obesity</keyword>
</DOC>